Difference between revisions of "Part:BBa K3714010"

Line 3: Line 3:
 
<partinfo>BBa_K3714010 short</partinfo>
 
<partinfo>BBa_K3714010 short</partinfo>
  
To test our optimization design with TMSD, a structureless toehold site between biotin probe binding site and aptazyme domain was need. However, designing the probe with manual work and test with available RNA structure prediction model is such a huge work with plenty of attempts.  
+
To test our optimized design with TMSD(toehold mediated strand displacement) reaction, a toehold site between biotin probe binding site and aptazyme domain is necessary. However, designing the probe manually and testing with available RNA structure prediction model is a huge work with consuming much labor.  
This part is designed by our probe design model and verified by the prediction model of team: SJTU-Software. And the changed probe shows no influence on the function of aptazyme, the toehold worked as our expect as well.
+
This part was designed by our probe design model and verified by the prediction model of team: SJTU-Software. And the changed sequences shows no influence on the function of aptazyme, the toehold worked as our expect as well (Figure.1).  
 
+
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Revision as of 02:21, 22 October 2021


Improved gard-337 for lateral flow assay

To test our optimized design with TMSD(toehold mediated strand displacement) reaction, a toehold site between biotin probe binding site and aptazyme domain is necessary. However, designing the probe manually and testing with available RNA structure prediction model is a huge work with consuming much labor. This part was designed by our probe design model and verified by the prediction model of team: SJTU-Software. And the changed sequences shows no influence on the function of aptazyme, the toehold worked as our expect as well (Figure.1).

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


K3714016.png
Figure.1 | Verification of temporarily inhibition and disinhibition by oligonucleotides. The aptazyme was produced by a T7 in vitro transcription system. The product was run on a denatured PAGE. Gardiquimod is an inhibitor of the cleavage activity. "stop" and "start" are two oligonucleotides designed to control the activity of the aptazyme/